Published in Adv Exp Med Biol on January 01, 1986
Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage. J Clin Invest (1987) 0.95
Adenosine triphosphate turnover in humans. Decreased degradation during relative hyperphosphatemia. J Clin Invest (1989) 0.86
Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1990) 0.76
A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol (2000) 3.28
Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J (1982) 2.91
Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase. Biochem J (1980) 2.88
The control of glycogen metabolism in the liver. Annu Rev Biochem (1976) 2.85
Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79
Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem (1983) 2.63
The abnormalities of lysosomal enzymes in mucopolysacc- haridoses. Eur J Biochem (1968) 2.55
Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-biphosphate. Proc Natl Acad Sci U S A (1981) 2.44
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol (1983) 2.10
The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats. The mechanism of the hepatic threshold to glucose. Eur J Biochem (1974) 2.10
Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes. Proc Natl Acad Sci U S A (1976) 2.04
The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J (1977) 1.96
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J (1995) 1.94
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A (1981) 1.91
Control of gluconeogenesis and of enzymes of glycogen metabolism in isolated rat hepatocytes. A parallel study of the effect of phenylephrine and of glucagon. Biochem J (1978) 1.81
The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase. Eur J Biochem (1975) 1.80
Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes (1991) 1.75
Fructose-2,6-bisphosphatase from rat liver. Eur J Biochem (1982) 1.75
Phosphorylation of glucose in isolated rat hepatocytes. Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J (1978) 1.70
Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo. Biochem J (1980) 1.69
Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64
Hormonal and ionic control of the glycogenolytic cascade in rat liver. Biochem J (1977) 1.64
A kinetic study of the soluble 5'-nucleotidase of rat liver. Biochem J (1977) 1.62
An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet (1984) 1.61
Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP. Biochem Biophys Res Commun (1981) 1.58
Regulation in vitro and in vivo of adenosine 3':5'-monophosphate-dependent inactivation of rat-liver pyruvate kinase type L. Eur J Biochem (1977) 1.57
Mucopolysaccharidosis by absence of alpha-fucosidase. Lancet (1968) 1.56
Purine catabolism in isolated rat hepatocytes. Influence of coformycin. Biochem J (1980) 1.52
Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci U S A (1983) 1.52
Recovery from AKI in the critically ill: potential confounders in the evaluation. Intensive Care Med (2015) 1.45
Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des (2008) 1.42
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med (1997) 1.39
The control of liver glycogen synthetase phosphatase by phosphorylase. Eur J Biochem (1971) 1.37
Fructose: metabolism and short-term effects on carbohydrate and purine metabolic pathways. Prog Biochem Pharmacol (1986) 1.37
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet (2001) 1.34
Formation of fructose 2,6-bisphosphate from fructose 1,6-bisphosphate by intramolecular cyclisation followed by alkaline hydrolysis. Eur J Biochem (1981) 1.31
Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis. Eur J Biochem (1972) 1.30
Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim Biophys Acta (1996) 1.30
The role of glucose, glucagon and glucocorticoids in the regulation of liver glycogen synthesis. Eur J Biochem (1968) 1.29
Glycogen metabolism in the liver of the foetal rat. Biochem J (1974) 1.29
The stimulation of yeast phosphofructokinase by fructose 2,6-bisphosphate. FEBS Lett (1982) 1.27
Synthesis of a stimulator of phosphofructokinase, most likely fructose 2,6-bisphosphate, from phosphoric acid and fructose 6-phosphoric acid. Biochem Biophys Res Commun (1980) 1.26
The control of glycogen synthesis in the liver. Adv Enzyme Regul (1970) 1.25
The control of glycogen metabolism in yeast. 1. Interconversion in vivo of glycogen synthase and glycogen phosphorylase induced by glucose, a nitrogen source or uncouplers. Eur J Biochem (1988) 1.23
Congenital folate malabsorption. Eur J Pediatr (1985) 1.22
On the use of (3H, 14C)labelled glucose in the study of the so-called "futile cycles" in liver and muscle. Biochem Biophys Res Commun (1974) 1.22
Concentration dependence and time course of the effects of glucose on adenine and guanine nucleotides in mouse pancreatic islets. J Biol Chem (1996) 1.20
Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency. Biochem J (1975) 1.20
Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med (1995) 1.17
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16
The effect of glucose and of a treatment by glucocorticoids on the activation in vitro of liver glycogen synthetase. Eur J Biochem (1970) 1.15
The stimulation of glycogen synthesis and of glycogen synthetase in the liver by the administration of glucose. Eur J Biochem (1967) 1.15
The interaction of liver phosphorylase a with glucose and AMP. Eur J Biochem (1974) 1.15
Induction of pyrophosphate:fructose 6-phosphate 1-phosphotransferase by anoxia in rice seedlings. Plant Physiol (1990) 1.14
Inactivation of phosphofructokinase 2 by cyclic AMP - dependent protein kinase. Biochem Biophys Res Commun (1981) 1.12
A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nat Genet (1992) 1.11
A study of the reaction catalysed by the liver branching enzyme. Biochem J (1966) 1.11
The influence of inorganic phosphate, adenosine triphosphate and glucose 6-phosphate on the activity of liver glycogen synthetase. Eur J Biochem (1968) 1.11
On the mechanism of inhibition of neutral liver fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. Eur J Biochem (1983) 1.11
Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med (2001) 1.11
A molecular order in the synthesis and degradation of glycogen in the liver. Eur J Biochem (1979) 1.10
Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Biochem J (1992) 1.09
The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem J (1984) 1.09
The pathway of adenine nucleotide catabolism and its control in isolated rat hepatocytes subjected to anoxia. Biochem J (1982) 1.09
Hypoglycaemic effect of AICAriboside in mice. Diabetologia (1996) 1.08
Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr (1988) 1.08
Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance. Biochem J (1973) 1.08
The mechanism by which glucose increases fructose 2,6-bisphosphate concentration in Saccharomyces cerevisiae. A cyclic-AMP-dependent activation of phosphofructokinase 2. Eur J Biochem (1984) 1.07
Effects of glucose and glucagon on the fructose 2,6-bisphosphate content of pancreatic islets and purified pancreatic B-cells. A comparison with isolated hepatocytes. Biochem J (1984) 1.07
Metabolic effects of fructose in the liver. Curr Top Cell Regul (1978) 1.06
Utile and futile cycles in the liver. Biochem Biophys Res Commun (1974) 1.06
Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle. Eur J Biochem (1986) 1.06
Characterization of trehalose-6-phosphate synthase and trehalose-6-phosphate phosphatase of Saccharomyces cerevisiae. Eur J Biochem (1989) 1.06
The subgroups of type 3 glycogenosis. Eur J Biochem (1967) 1.05
Fructose 2,6-bisphosphate versus cyclic AMP in the liver and in lower eukaryotic cells. Curr Top Cell Regul (1985) 1.05
Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem (1987) 1.05
Interference by pyruvate carboxylase in the measurement of acetyl-CoA carboxylase in crude liver preparations. Biochem J (1982) 1.05
A simplified procedure for the assay of adenosine 3':5'-monophosphate by the activation of liver phosphorylase. Eur J Biochem (1974) 1.04
Purification and properties of spinach leaf phosphofructokinase 2/fructose 2,6-bisphosphatase. Eur J Biochem (1986) 1.04
Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency. Hum Mol Genet (2000) 1.03
The effect of glucose and of a treatment by glucocorticoids on the inactivation in vitro of liver glycogen phosphorylase. Eur J Biochem (1970) 1.03
Pathways of adenine nucleotide catabolism in erythrocytes. J Clin Invest (1986) 1.03
Treatment of epidemic typhus. A comparative study of chloramphenicol, trimethoprim-sulphamethoxazole and doxycycline. Trans R Soc Trop Med Hyg (1973) 1.02
The interconversion of liver glycogen synthetase a and b in vitro. Eur J Biochem (1968) 1.02
ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens. Br J Pharmacol (1992) 1.00
Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J Inherit Metab Dis (1997) 0.99
Substrate cycling between 5-amino-4-imidazolecarboxamide riboside and its monophosphate in isolated rat hepatocytes. Biochem Pharmacol (1996) 0.98